SPHK1 and Alzheimer disease: The study also reported that during AD pathology, Sphk1 expression was decreased, shifting the COX2 activity toward prostanoid synthesis and impeding the production of SPMs [35]; in short, this explains the poor resolution of inflammation due to the abrogated communication between Sphk1, COX2, and SPMs.